A new type of lens approved by the FDA promises to slow nearsightedness in children.
Jaguar’s requesting advice from EMA on EU approval pathway for general diarrhea of FDA conditionally approved Canalevia® A ...
A new drug that treats adults with acute myeloid leukemia, and three years after Roswell enrolled the first patient to use ...
Phoenix NP announced an expansion of its service availability across Arizona to help more women access FDA-approved GLP-1 weight loss medications through compliant, manufacturer-direct pharmacies. The ...
The FDA has approved an adeno-associated virus 9 gene replacement therapy to treat individuals aged 2 years and older with ...
A San Diego medical technology company received FDA approval this morning for a device that could transform how patients get ...
In March 2025, the FDA approved OMLYCLO in 75 mg/0.5 mL and 150 mg/mL solutions in a single-dose prefilled syringe for subcutaneous injection for the treatment of moderate to severe persistent asthma, ...
ESTERO, FLORIDA / ACCESS Newswire / December 2, 2025 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) (“Aspire” or the “Company”), a developer of a multi-faceted patent-pending drug delivery technology ...
The US Food and Drug Administration (FDA) has approved Amneal Pharmaceuticals’ cyclosporine ophthalmic emulsion 0.05%, which is is the generic equivalent of RESTASIS 0.05%, a registered trademark of ...
A once-beleaguered gene-therapy stock just landed a major vote of confidence—and the timing seems anything but accidental.
Doctors in the Raquel and Jaime Gilinski Department of Obstetrics, Gynecology and Reproductive Science at Mount Sinai have ...
Amneal Pharmaceuticals received Food and Drug Administration approval for its albuterol sulfate inhalation aerosol to treat bronchospasm in people with reversible obstructive airway disease. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback